HC Wainwright & Co. reiterated coverage on Sol-Gel Technologies with a new price target
$SLGL
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. reiterated coverage of Sol-Gel Technologies with a rating of Buy and set a new price target of $21.00 from $20.00 previously